\BOOKMARK [0][-]{section*.4}{Glossary}{}% 1
\BOOKMARK [0][-]{section*.6}{Acronyms}{}% 2
\BOOKMARK [0][-]{chapter*.7}{References}{}% 193
\BOOKMARK [0][-]{appendix.C}{Mutation Analysis in Breast Cancer}{}% 198
\BOOKMARK [1][-]{section.C.1}{Synthetic Lethal Genes and Pathways}{appendix.C}% 199
\BOOKMARK [1][-]{section.C.2}{Synthetic Lethal Expression Profiles}{appendix.C}% 200
\BOOKMARK [1][-]{section.C.3}{Comparison to Primary Screen}{appendix.C}% 201
\BOOKMARK [2][-]{subsection.C.3.1}{Resampling Analysis}{section.C.3}% 202
\BOOKMARK [1][-]{section.C.4}{Compare SLIPT genes}{appendix.C}% 203
\BOOKMARK [1][-]{section.C.5}{Metagene Analysis}{appendix.C}% 204
\BOOKMARK [1][-]{section.C.6}{Expression of Somatic Mutations}{appendix.C}% 205
\BOOKMARK [1][-]{section.C.7}{Metagene Expression Profiles}{appendix.C}% 206
\BOOKMARK [0][-]{appendix.D}{Intrinsic Subtyping}{}% 207
\BOOKMARK [0][-]{appendix.E}{Stomach Expression Analysis}{}% 208
\BOOKMARK [1][-]{section.E.1}{Synthetic Lethal Genes and Pathways}{appendix.E}% 209
\BOOKMARK [1][-]{section.E.2}{Comparison to Primary Screen}{appendix.E}% 210
\BOOKMARK [2][-]{subsection.E.2.1}{Resampling Analysis}{section.E.2}% 211
\BOOKMARK [1][-]{section.E.3}{Metagene Analysis}{appendix.E}% 212
\BOOKMARK [0][-]{appendix.F}{Stomach Mutation Analysis}{}% 213
\BOOKMARK [1][-]{section.F.1}{Synthetic Lethal Genes and Pathways}{appendix.F}% 214
\BOOKMARK [1][-]{section.F.2}{Synthetic Lethal Expression Profiles}{appendix.F}% 215
\BOOKMARK [1][-]{section.F.3}{Comparison to Primary Screen}{appendix.F}% 216
\BOOKMARK [2][-]{subsection.F.3.1}{Resampling Analysis}{section.F.3}% 217
\BOOKMARK [1][-]{section.F.4}{Metagene Analysis}{appendix.F}% 218
\BOOKMARK [0][-]{appendix.G}{Global Synthetic Lethality in Stomach Cancer}{}% 219
\BOOKMARK [1][-]{section.G.1}{Hub Genes}{appendix.G}% 220
\BOOKMARK [1][-]{section.G.2}{Hub Pathways}{appendix.G}% 221
\BOOKMARK [0][-]{appendix.H}{Replication in cell line encyclopaedia}{}% 222
